Enanta Pharmaceuticals (ENTA) Treasury Shares (2012 - 2026)
Enanta Pharmaceuticals (ENTA) reported Treasury Shares of $2000.0 for Q2 2015, little changed on a YoY basis from $2000.0 in Q2 2014, and little changed quarter-over-quarter from $2000.0 in Q1 2015.
Enanta Pharmaceuticals (ENTA) Treasury Shares (2012 - 2026) Analysis & Trends
Enanta Pharmaceuticals has reported Treasury Shares for 4 years, with the latest figure at $2000.0 in Q2 2015.
- For the quarter ending Q2 2015, Treasury Shares changed 0.0% year-over-year to $2000.0; the trailing twelve-month figure through Jun 2015 stood at $2000.0 (changed 0.0% YoY), and the FY2014 full-year result was $2000.0, changed 0.0% from the prior year.
- Treasury Shares for Q2 2015 stood at $2000.0, roughly flat from $2000.0 in the prior quarter.
- The five-year high for Treasury Shares was $427000.0 in Q1 2025, with the low at $81000.0 in Q1 2023.
- Historically, Treasury Shares has averaged $191294.1 across 5 years, with a median of $129000.0 in 2023.
- The largest YoY upside for Treasury Shares was 0.0% in 2013 against a maximum downside of 0.0% in 2013.
- Enanta Pharmaceuticals' Treasury Shares stood at $2000.0 in 2012, then changed by 0.0% to $2000.0 in 2013, then changed by 0.0% to $2000.0 in 2014, then changed by 0.0% to $2000.0 in 2015.
- The last three Treasury Shares figures came in at $2000.0 (Q2 2015), $2000.0 (Q1 2015), and $2000.0 (Q4 2014), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Enanta Pharmaceuticals | 365.48 Mn | 201.71 Mn | - | 104,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 104,000.00 |
| Mar 31, 2026 | 104,000.00 |
| Dec 31, 2025 | 151,000.00 |
| Dec 31, 2025 | 151,000.00 |
| Sep 30, 2025 | 408,000.00 |
| Sep 30, 2025 | 408,000.00 |
| Jun 30, 2025 | 414,000.00 |
| Jun 30, 2025 | 414,000.00 |
| Mar 31, 2025 | 427,000.00 |
| Mar 31, 2025 | 427,000.00 |
| Dec 31, 2024 | 92,000.00 |
| Dec 31, 2024 | 92,000.00 |
| Sep 30, 2024 | 92,000.00 |
| Sep 30, 2024 | 92,000.00 |
| Jun 30, 2024 | 92,000.00 |
| Jun 30, 2024 | 92,000.00 |
| Mar 31, 2024 | 88,000.00 |
| Mar 31, 2024 | 88,000.00 |
| Dec 31, 2023 | 129,000.00 |
| Dec 31, 2023 | 129,000.00 |